These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8540821)

  • 21. Influence of cognitive reserve on neuropsychologic functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality.
    Sánchez JL; Rodríguez M; Carro J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):113-22. PubMed ID: 12050474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment.
    Bennys K; Portet F; Touchon J; Rondouin G
    J Clin Neurophysiol; 2007 Oct; 24(5):405-12. PubMed ID: 17912065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuropsychological and behavioural assessment in Alzheimer's disease].
    Accorrà D; Mazzarini L; Girardi P; Ruberto A; Kotzalidis GD; Tatarelli R
    Ann Ist Super Sanita; 2004; 40(4):485-93. PubMed ID: 15815116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive topographical disorientation: a case of focal Alzheimer's disease.
    Grossi D; Fasanaro AM; Cecere R; Salzano S; Trojano L
    Neurol Sci; 2007 Apr; 28(2):107-10. PubMed ID: 17464476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease.
    Levine AJ; Battista M
    Arch Clin Neuropsychol; 2004 Sep; 19(6):769-78. PubMed ID: 15288330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A proposal for diagnostic and clinical assessment criteria for Alzheimer's disease].
    Shoji M; Kuwano R; Asada T; Imagawa M; Higuchi S; Urakami K; Arai H; Ihara Y; ;
    Rinsho Shinkeigaku; 2005 Feb; 45(2):128-37. PubMed ID: 15782613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic spontaneous cerebral emboli predict cognitive and functional decline in dementia.
    Purandare N; Voshaar RC; Morris J; Byrne JE; Wren J; Heller RF; McCollum CN; Burns A
    Biol Psychiatry; 2007 Aug; 62(4):339-44. PubMed ID: 17531959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognition and behavior in patients with Alzheimer's disease.
    Ott BR
    J Gend Specif Med; 1999; 2(3):63-9. PubMed ID: 11252854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of NMR spectroscopy in exploring the cerebral metabolism of patients affected by Alzheimer's disease].
    Bissuel Y; Mecher G; Mehier H; Dalery J; Terra JL; Roussel B; Marie-Cardine M
    Encephale; 1993; 19(1):29-35. PubMed ID: 8275891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease: relationship of cognition and behavior to neurochemistry.
    Whitehouse PJ
    Int Psychogeriatr; 1992; 4 Suppl 1():71-8. PubMed ID: 1354507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alzheimer's disease: concept and diagnostic criteria].
    Miyoshi K
    Nihon Rinsho; 2004 Jan; 62 Suppl():41-5. PubMed ID: 15011317
    [No Abstract]   [Full Text] [Related]  

  • 37. Cognitive Assessment in Alzheimer's Disease Clinical Trials.
    Price G
    Methods Mol Biol; 2018; 1750():355-362. PubMed ID: 29512085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pupil in Alzheimer's disease].
    Berciano J
    Neurologia; 1995 Feb; 10(2):63-4. PubMed ID: 7695944
    [No Abstract]   [Full Text] [Related]  

  • 39. [Heterogeneity of cognitive deficits in Alzheimer's and cognition therapy: research design ].
    Bier N; Gagnon L; Desrosiers J
    Can J Aging; 2005; 24(3):275-84. PubMed ID: 16421851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some workmen can blame their tools: artistic change in an individual with Alzheimer's disease.
    Crutch SJ; Isaacs R; Rossor MN
    Lancet; 2001 Jun; 357(9274):2129-33. PubMed ID: 11445128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.